Your browser doesn't support javascript.
loading
Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
Matsunaga, T; Yamaji, Y; Tomokuni, T; Morita, H; Morikawa, Y; Suzuki, A; Yonezawa, A; Endo, S; Ikari, A; Iguchi, K; El-Kabbani, O; Tajima, K; Hara, A.
Affiliation
  • Matsunaga T; Laboratory of Biochemistry, Gifu Pharmaceutical University , Gifu , Japan.
Free Radic Res ; 48(11): 1371-85, 2014 Nov.
Article in En | MEDLINE | ID: mdl-25156503
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Aldehyde Reductase / Drug Resistance, Neoplasm / Proteasome Endopeptidase Complex / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Free Radic Res Journal subject: BIOQUIMICA Year: 2014 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Aldehyde Reductase / Drug Resistance, Neoplasm / Proteasome Endopeptidase Complex / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Free Radic Res Journal subject: BIOQUIMICA Year: 2014 Document type: Article Affiliation country: Japón